Cooper Companies

The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cooper Companies excels in Q1, eyes growth through strategic initiatives

Cooper Companies delivered exceptional Q1 results, surpassing revenue and earnings expectations. With a focus on innovation, operational efficiency, and strategic acquisitions, the company is well-positioned for continued growth despite economic uncertainties and supply chain challenges.

Cooper Companies reports record Q2 revenues amidst industry challenges

Cooper Companies delivered a strong Q2 performance with record revenues and solid earnings per share, driven by CooperVision and CooperSurgical.
While facing industry-wide supply chain challenges, Cooper's strategic strengths in product portfolios and geographic diversification position it well for future growth.
Opportunities lie in leveraging successful product lines, addressing operational challenges, and expanding into international markets for sustained growth.
Overall, Cooper remains optimistic about its future growth prospects in the contact lens and fertility markets, despite facing some challenges.

Cooper Companies reports record revenues and optimistic outlook for growth

Cooper Companies delivered strong financial performance, exceeding revenue expectations and showcasing growth in key segments. The company is strategically positioned for sustained growth, with a focus on leveraging market opportunities and optimizing infrastructure investments. Challenges in managing growth and SKU ranges are being addressed to drive future profitability.

Cooper Companies reports record revenues and projects strong growth ahead

Cooper Companies had a stellar year, marked by record revenues and robust growth in key segments. Despite challenges in capacity and cash flow, the company is poised for continued success with confidence in overcoming obstacles. Opportunities in Myopia management, price trends, and share gains position Cooper Companies for a promising future.

Cooper Companies reports record Q1 revenues, eyes global growth opportunities

Cooper Companies delivered a strong Q1 performance with record revenues and raised full-year guidance. The company's focus on key growth areas like myopia management and daily contact lenses bodes well for future success. Addressing challenges in capacity constraints and market fluctuations will be crucial for sustained growth.

Cooper Companies (COO) reports record revenues and growth opportunities

Cooper Companies (COO) reports strong Q2 earnings with record revenues and increased guidance for fiscal 2024. Challenges include system upgrade impact and competitive uncertainties, but opportunities lie in market growth and strategic investments for future growth.

Cooper Companies (COO) excels in Q3 with record revenues and growth

Cooper Companies (COO) showcased robust financial performance in Q3 2024, driven by record revenues and earnings growth across its key segments.
While facing challenges in certain product lines, strategic investments and market-leading positions position the company well for future growth and profitability.
With a focus on innovation and operational excellence, Cooper Companies is poised to capitalize on opportunities for sustained success and market expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cooper Cos. (COO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Can Cooper Cos. (COO) Keep the Earnings Surprise Streak Alive?

The Cooper Companies (COO) arm's buyout drives its growing portfolio of medical products, which revolves around clinic and practice-based women's healthcare

The Cooper Companies (COO) Unit Gets a Boost From New Buyout

Employees give company culture high marks for fairness, respect, and pride Employees give company culture high marks for fairness, respect, and pride

CooperCompanies Awarded Great Place to Work® Certification

Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.

Here's Why You Should Retain Cooper Companies (COO) Stock

SAN RAMON, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will present virtually at the J.P. Morgan Healthcare Conference on January 12, 2021. Al White, President and CEO, will represent the Company in a presentation scheduled to begin at 12:40PM PT (3:40PM ET).

CooperCompanies to Present at J.P. Morgan Healthcare Conference

SAN RAMON, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) announced today that A. Thomas Bender and Allan E. Rubenstein, M.D. have decided to retire and will not stand for re-election at the Annual Meeting of Stockholders in March 2021. Both men have held multiple board roles spanning decades, and their guidance has been instrumental in the success of the CooperCompanies. They have helped position the company for many years of future success.

A. Thomas Bender and Allan E. Rubenstein, M.D.

Cooper Companies' (COO) fiscal fourth-quarter earnings reflect weak segmental performance. However, it exceeds expectation as it witnesses faster-than-anticipated recovery.

Cooper Companies (COO) Q4 Earnings & Revenues Top Estimates

The Cooper Companies, Inc. (COO) CEO Al White on Q4 2020 Results - Earnings Call Transcript

Cooper Cos. (COO) delivered earnings and revenue surprises of 1.61% and 0.38%, respectively, for the quarter ended October 2020.

Cooper Cos. (COO) Q4 Earnings and Revenues Beat Estimates

Shares of Cooper Companies (NYSE:COO) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 4.24% year over year to $3.16, which beat the estimate of $3.09.

Cooper Companies: Q4 Earnings Insights

SAN RAMON, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal fourth quarter and full year ended October 31, 2020.

CooperCompanies Announces Fourth Quarter and Full Year 2020 Results

Cooper Cos. (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

Earnings Preview: Cooper Cos. (COO) Q4 Earnings Expected to Decline

Here's Why You Should Invest in Cooper Companies (COO) Stock

SAN RAMON, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) announced today that its Board of Directors elected Teresa S. Madden to the Board as an independent director, effective December 1, 2020.

CooperCompanies Elects Teresa S. Madden to Board of Directors

Patterson Companies

PDCO vs. COO: Which Stock Is the Better Value Option?

In this article we are going to use hedge fund sentiment as a tool and determine whether The Cooper Companies, Inc. (NYSE:COO) is a good investment right now. We like to analyze hedge fund sentiment before conducting days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy League graduates, expert network advisers, and supply chain tipsters working or consulting for them. There is not a shortage of news stories covering failed hedge fund investments and it is a fact that hedge funds' picks don't beat the market 100% of the time, but their consensus picks have historically done very well and have outperformed the market after adjusting for risk.

Were Hedge Funds Right About Piling Into The Cooper Companies, Inc. (COO)?

SAN RAMON, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will release fourth quarter and full year 2020 financial results on Thursday, December 3, 2020, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2020

AmerisourceBergen

Align Technology

Becton, Dickinson and Co.

Cardinal Health

Henry Schein

Labcorp Holdings Inc

McKesson

West Pharmaceutical Services

DENTSPLY SIRONA

3 Dental Supplies Stocks Set to Shine on the Industry's Upturn

After a 43% rise since the March 23 lows of this year, at the current price of around $348 per share we believe Cooper stock (NYSE: COO), best known for its Cooper Vision lenses, has reached its near-term potential. Cooper's stock has rallied from $243 to around $350 off the recent bottom

After A 40% Rally Can Cooper Stock See Further Gains?

Data from NYU Langone Fertility Center Study P resented at  American Society of Reproductive Medicine Annual Meeting

CooperSurgical and NYU Langone Fertility Center Announce Study Data Showing Significant Increase in Ongoing Pregnancy and Live Birth Rates with Genetic Test Using Artificial Intelligence (PGTai 2.0 platform) for Patients Undergoing IVF

Cooper Cos. (COO) reported earnings 30 days ago.

Why Is Cooper Cos. (COO) Up 9.3% Since Last Earnings Report?

SmileDirectClub

Let's keep a watch on potentially strong three stocks in the dental space that have shown promise during the pandemic.

Dental Market Picks Up Pace Amid COVID-19: 3 Stocks to Watch

American Water Works

NextEra Energy

Losing sleep over Tesla's dramatic ups and downs? Consider these conservative choices, so you're not left tossing and turning all night.

Tired of the Tesla Roller Coaster? Try These Safer Stocks Instead

CooperCompanies, CooperVision and CooperSurgical All Recognized by Fortune Magazine CooperCompanies, CooperVision and CooperSurgical All Recognized by Fortune Magazine

CooperCompanies and Divisions Named One of Fortune’s Best Large Workplaces in Manufacturing and Production

The Cooper (COO) saw a big move last session, as its shares jumped nearly 5% on the day, amid huge volumes.

News for Cooper Companies Stock (COO)